Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors

MLA

Sadanori Takeo, et al. “Pretreatment Prognostic Nutritional Index as a Novel Biomarker in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.” Lung Cancer (Amsterdam, Netherlands), vol. 136, June 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....858ce7a33ff4990464ae3db741d76716&authtype=sso&custid=ns315887.

APA

Sadanori Takeo, Gouji Toyokawa, Hiroaki Takeoka, Yuka Kozuma, Masao Ichiki, Koji Yamazaki, & Fumihiro Shoji. (2019). Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Lung Cancer (Amsterdam, Netherlands), 136.

Chicago

Sadanori Takeo, Gouji Toyokawa, Hiroaki Takeoka, Yuka Kozuma, Masao Ichiki, Koji Yamazaki, and Fumihiro Shoji. 2019. “Pretreatment Prognostic Nutritional Index as a Novel Biomarker in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.” Lung Cancer (Amsterdam, Netherlands) 136 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....858ce7a33ff4990464ae3db741d76716&authtype=sso&custid=ns315887.